Symposium Updates Knowledge of Zika Virus and Countermeasures
October 28th 2016Zika has been around for a long time, with the first report dating back to 1947. Until 2007, only 14 cases had been reported. Subsequently, there have been three outbreaks, culminating with its arrival in the Americas in the 2015 epidemic in Brazil.
ASPIRE HIV Prevention Study Reveals Several Key Findings
October 26th 2016During the 2016 HIV Research and Prevention (HIVR4P) meeting in Chicago, researchers conducting trials to assess the safety and efficacy of the dapivirine vaginal ring announced several key findings and insights of the ASPIRE study, known as MTN-020.
UNICEF Announces New Deal for Low-cost Five-in-one Vaccine for Children
October 25th 2016The United Nations Children’s Fund (UNICEF) has partnered with six vaccine makers and the Global Alliance for Vaccines and Immunization (GAVI) to offer 450 million doses of an inexpensive pentavalent vaccine for children.
HPV Vaccine May Need a Redesign Due to Changes in Circulating Strains
October 22nd 2016Changes in strain prevalence indicate that the existing 9-valent HPV vaccines may offer some protection against an additional high-risk strain that is not included in the vaccine (strain 31), potentially due to antigenic similarities with other strains.
New Tuberculosis Treatment Uses Old Antibiotics in Novel Ways
October 20th 2016While health officials continue to search for more novel tools to fight tuberculosis, a team of researchers has found that a class of antibiotics first introduced in the 1960s may offer an important weapon against the outbreaks of today.
Researchers Discover Effective Vaccine Program for Dengue-Affected Countries
October 20th 2016Researchers at Sanofi Pasteur, have developed a “transmission model” for Dengue and assessed the population impact of vaccination in the 10 countries participating in the Phase III efficacy studies for CYD-TDV/Dengvaxia.